Regulatory clarification on the use of nanoparticles in masks

.
.
.
Newsflash
covid-19 masks biocide regulation

In a notice to operators, the DGCCRF and ANSM recalled some essential points to be considered before marketing surgical masks. In particular, the risks related to the presence of a biocidal substance or material must be assessed and that this assessment must take into account, among others, the particular risk of exposure to nanoparticles.

If the mask incorporates a nanomaterial, it will fall under Class IIa, IIb, or III with respect to internal exposure potential under Regulation (EU) 2017/745 on medical devices and this will therefore require the involvement of a notified body.

Upcoming Nano Agenda

21
Jan.
2025
Nano-objects: detect, characterize and quantify them with the new experimental standard (Afnor, Online)
On line
Webinar
  • Webconference
  • Program:
    • Presentation of the experimental standard CEN ISO/TS 19590, entitled “Nanotechnologies – Characterization of nano-objects by inductively coupled plasma mass spectrometry in single particle mode”.
    • Users’ feedbacks
  • Organizer: AFNOR
  • Website: www.afnor.org/…/nano-objets…
30
Jan.
2025
Research and stakeholders meeting (ANSES, Maisons-Alfort)
Maisons-Alfort
Forum
18
Mars
2025
C’Nano 2025: The Nanoscience Meeting (C’Nano – Paris, France)
Paris
Congress
  • 6th interdisciplinary nanoscience congress, dedicated to all academic and industrial scientists in nanoscience and nanotechnology, including researchers, engineers, PhD students, post-docs, etc.
  • March 18 to 21, 2025
  • Organizers: Centre national de Compétences en Nanosciences du CNRS, C’Nano
  • Website: https://cnano2025.sciencesconf.org